Despite China, NY Fed Dudley Still Expects Fed Rate Hike
Unfortunately, most of his speech was broader, about the changing developments and reinvention of the modern workforce, rather than being pointed about any major direction on interest rates.
All Work
Jon C. Ogg
Wells Fargo Sees Value in AerCap
Wells Fargo has added AerCap to the firm's Priority Stock List after its earnings report on Tuesday.
Job Openings and Labor Turnover Make for Healthy Jobs Market
Despite a one-month lag, the JOLTS report gives a very clear and concise insider's eye view of the real workings inside the jobs market.
Credit Suisse Opines on Chinese Devaluation
Credit Suisse's Andrew Garthwaite has taken a look at the renminbi devaluation. His view is that China will end up depreciating a little more than the forward curve is currently anticipating.
Will a Boutique Analyst Upgrade Help Iconix Brand Group?
Iconix Brand Group finally may have found one stabilizing agent for its shrinking share price in an upgrade from a boutique analyst.
Top Analyst Upgrades and Downgrades: Annaly, Gap, Google, Johnson Controls, Symantec, Williams, Yelp and Many More
Wednesday's top analyst upgrades, downgrades and initiations include Annaly Capital Management, Gap, Google, Johnson Controls, Symantec, Williams Companies and Yelp.
5 Top BioPharma Stocks That May Have Sold Off Too Much and Become Bargains
It may be impossible to ever know if a true bottom has ever been seen, but many investors love finding great companies where they feel that a sell-off has overly punished the share price.
Why Anadarko Could Be Worth 40% More, or Even a Buyout Candidate
ThinkstockAnadarko Petroleum Corp. (NYSE: APC) has been called a great value in the oil and sector before, but times like these in the oil and gas sector bring very few analyst upgrades of any…
Orbital ATK Raised to Buy at Argus
ThinkstockOrbital ATK, Inc. (NYSE: OA) has an upcoming investor presentation this week at the Jefferies Industrials Conference. It seems that one other analyst thinks there is value here now that the Orbital-Alliant merger and…
When Apple Has 2 Analyst Downgrades and a Weak Chart at the Same Time
Apple is the worst drag on the Dow Jones Industrial Average as investors have been growing worried.
Analysts Rate MCBC Holdings, MasterCraft Boats
MCBC has not been very exciting since its mid-July initial public offering. Now its quiet period has now ended and analysts from the underwriting firms can issue their analyst coverage.
How Analysts Rate Ooma After Quiet Period
Ooma has now seen its initial public offering quiet period come to an end, and analysts are not really driving this stock higher in their calls.
June Wholesale Trade Could Impact GDP Revision
The reading for wholesale trade in June came out with some mixed fanfare on Tuesday. It will play into GDP revisions for the second quarter.
Nonfarm Productivity Ticks Back Up With Rise in Labor Costs
Nonfarm productivity managed to post a small gain in the second quarter of 2015. While that gain was smaller than expected, there may be some relief here that productivity went back up.
Goldman Sachs Sees Mixed View on Private Equity and Alternative Managers
Goldman Sachs started coverage on the private equity and alternative asset management and hedge funds on Tuesday.
Top Analyst Upgrades and Downgrades: Adobe, Biogen, Google, PDC Energy, Rackspace, XL Group and Many More
Tuesday's top analyst upgrades, downgrades and initiations include Adobe, Biogen, Google, PDC Energy, Rackspace and XL Group.
Google Throws Massive Curveball in New Structure: Alphabet vs. Google
Google will to be asking shareholders to trust management, albeit new management. Without much surprise, Google shares rose 5% or so in the after-hours session on this news.
Should Gap and Dillard’s Both Have Been Downgraded at JPMorgan?
What happens when investors see two key downgrades an in the retail and apparel sector that seem like calls that are late to the party?
Why AbbVie Should Be Worth 25% More
Independent research firm Argus has maintained its Buy rating and its $85.00 price target on AbbVie.
Is Cannabis Biotech Zynerba the Hottest Post-IPO of 2015?
ThinkstockZynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) had a solid run on Monday following the prior week’s initial public offering. The problem is that this deal was so small, and it came out during a serious…